Поясничная боль: возможности применения миорелаксантов

1. Батышева Т.Т., Попова Н.Ф., Камчатнов П.Р. и др. Результаты применения препарата сирдалуд МР у больных рассеянным склерозом. Журн. неврол. и психиатр. 2010; 110 (5): 47–51.
2. Дамулин И.В. Постинсультные двигательные расстройства. Cons. Med. 2003; 5 (2): 64–70.
3. Насонов Е.Л. Противовоспалительная терапия ревматических болезней. М.: М-Сити, 1996; с. 345.
4. Никифоров А.С., Авакян Г.Н. Неврологические осложнения остеохондроза позвоночника. Медпрактика 2011.
5. Abbruzzese G. The medical management of spasticity. Eur J Neurol 2002; 9 (Suppl. 1): 30–4.
6. Arroyo R, Vila C, Clissold S. Retrospective observational study of the management of multiple sclerosis patients with resistant spasticity in Spain: the '5E' study. Expert Rev Pharmacoecon Outcomes Res 2011; 11 (2): 205–13.
7. Chou R, Peterson K, Helfand M. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manage 2004; 28 (2): 140–75.
8. Chou R, Qaseem A, Snow V et al. Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society. Ann Intern Med 2007; 147: 478–91.
9. Deyo R, Rainville J, Kent D. What can the history and physical examination tell us about low back pain? JAMA 1992; 268: 760–5.
10. Fuchigami T, Kakinohana O, Hefferan M et al. Potent suppression of stretch reflex activity after systemic or spinal delivery of tizanidine in rats with spinal ischemia-induced chronic spastic paraplegia. Neuroscience 2011; 194: 160–9.
11. Gilbert F, Grant A, Gillan M et al. Scottish Back Trial Group. Low back pain: influence of early MR imaging or CT on treatment and outcome – multicenter randomized trial. Radiology 2004; 231: 343–51.
12. Groves L, Shellenberger M, Davis C. Tizanidine treatment of spasticity: a meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam. Adv Ther 1998; 15 (4): 241–51.
13. Hagen K, Jamtvedt G, Hilde G, Winnem M. Bed rest bad for back pain, ineffective for sciatica. The updated Cochrane Review of bed rest for low back pain and sciatica. Spine 2005; 30: 542–46.
14. Kamen L, Henney H, Runyan J. A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury. Curr Med Res Opin 2008; 24 (2): 425–39.
15. Ketenci A, Ozcan E, Karamursel S. Assessment of efficacy and psychomotor performances of thiocolchicoside and tizanidine in patients with acute low back pain. Int J Clin Pract 2005; 59 (7): 764–70.
16. Kheder A, Nair K. Spasticity: pathophysiology, evaluation and management. Pract Neurol 2012; 12 (5): 289–98.
17. Koes W, van Tulder M, Lin С et al. An updated overview of clinical guidelines for the management of non-specific low back pain in primary care. Eur Spine J 2010; 19: 2075–94.
18. Low Back pain initiavite. WHO 1999; p. 4.
19. Malanga G, Gwynn M, Smith R, Miller D. Tizanidine is effective in the treatment of myofascial pain syndrome. Pain Physician 2002; 5 (4): 422–32.
20. Malanga G, Reiter R, Garay E. Update on tizanidine for muscle spasticity and emerging indications. Expert Opin Pharmacother 2008; 9 (12): 2209–15.
21. Mathew N. Dynamic optimization of chronic migraine treatment: current and future options. Neurology 2009; 72 (Suppl. 5): S14–20.
22. Monticone M, Ferrante S, Rocca B et al. Effect of a Long- lasting Multidisciplinary Program on Disability and Fear-evoidance Behaviors in Patients with Chronic Low Back Pain: Results of a Randomized Controlled Trial. Clin J Pain 2013.
23. Pareek A, Chandurkar N, Chandanwale A еt al. Aceclofenac-tizanidine in the treatment of acute low back pain: a double-blind, double-dummy, randomized, multicentric, comparative study against aceclofenac alone. Eur Spine J 2009; 5: 67–72.
24. Pillastrini P, Gardenghi I, Bonetti F et al. An updated overview of clinical guidelines for chronic low back pain management in primary care. Joint Bone Spine 2012; 79 (2): 176–85.
25. Rossi M, Ianigro G, Liberatoscioli G et al. Eperisone versus tizanidine for treatment of chronic low back pain. Minerva Med 2012; 103 (3): 143–9.
26. Stevenson V. Rehabilitation in practice: Spasticity management. Clin Rehabil 2010; 24 (4): 293–304.
27. Tilton A, Vargus-Adams J, Delgado M. Pharmacologic treatment of spasticity in children. Semin Pediatr Neurol 2010; 17 (4): 261–7.
28. Van Tulder M, Becker A, Bekkering T et al. European guidelines for the management of acute nonspecific low back pain in primary care. Eur Spine J 2006; 15 (Suppl. 2): S169–S191.
29. Waddell G. The Back Pain Revolution ed. by G.Waddell. 2nd ed. Elsevier Edinburgh 2004; p. 221–39.

П.Р.Камчатнов, А.Ю.Казаков, А.Ф.Чугунов

ГБОУ ВПО РНИМУ им. Н.И.Пирогова Минздрава РФ, Москва